Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT04708470	TitlePhase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in Patients With Advanced Cancer	Fase Phase 1, Phase 2	Date Added 2021-01-14	Ubicación Maryland, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Bintrafusp alfa, Entinostat, NHS-IL12	Etiquetas MSS/ MMRp
NCT ID NCT04362839	TitleRegorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer	Fase Fase 1	Date Added 2020-04-27	Ubicación California, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Ipilimumab, Nivolumab, Regorafenib, Opdivo, Stivarga, Yervoy	Etiquetas MSS/ MMRp
NCT ID NCT04092673	TitleEstudio de eFT226 en sujetos con tumores sólidos malignos avanzados seleccionados	Fase Fase 1	Date Added 2019-09-17	Ubicación California, United States Michigan, United States Nevada, United States New Jersey, United States New York, United States Ohio, United States Texas, United States Virginia, United States	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas eFT226, eFT226	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03796884	TitleLinaclotide in Treating Patients With Stages 0-3 Colorectal Cancer	Fase Fase 2	Date Added 2019-01-08	Ubicación Pennsylvania, United States Washington, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Linaclotide	Etiquetas MSS/ MMRp
NCT ID NCT02864485	TitleTrasplante hepático de donante vivo para metástasis hepáticas de cáncer colorrectal irresecable	Fase No aplicable	Date Added 2016-08-12	Ubicación Canadá	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04050709	TitleQUILT 3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers	Fase Fase 1	Date Added 2019-08-08	Ubicación California, United States	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas PD-L1 t-haNK	Etiquetas MSS/ MMRp
NCT ID NCT02675946	TitleCGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)	Fase Fase 1	Date Added 2016-02-05	Ubicación California, United States Colorado, United States Connecticut, United States District of Columbia, United States Florida, United States Georgia, United States Hawaii, United States Illinois, United States Indiana, United States Maryland, United States Massachusetts, United States Nebraska, United States New Jersey, United States North Carolina, United States Pennsylvania, United States South Dakota, United States Tennessee, United States Texas, United States Washington, United States Wisconsin, United States Taiwán	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas cetuximab, CGX1321, encorafenib, Pembrolizumab, Keytruda	Etiquetas MSS/ MMRp
NCT ID NCT03608046	TitleAvelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer	Fase Fase 2	Date Added 2018-07-31	Ubicación Bélgica	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Avelumab, Cetuximab Injection, Irinotecan	Etiquetas MSS/ MMRp
NCT ID NCT03626922	TitleStudy of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients	Fase Fase 1	Date Added 2018-08-13	Ubicación Florida, United States Illinois, United States Michigan, United States Minnesota, United States Pennsylvania, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Dexamethasone, oxaliplatin, Pembrolizumab, Pemetrexed, Alimta, Eloxatin, Keytruda	Etiquetas MSS/ MMRp
NCT ID NCT03013218	TitleA Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)	Fase Fase 1	Date Added 2017-01-06	Ubicación Colorado, United States Connecticut, United States Massachusetts, United States Michigan, United States Washington, United States Corea, República de	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas 5-FU + Cisplatin, Evorpacept (ALX148), Pembrolizumab, Ramucirumab + Paclitaxel, Rituximab, Trastuzumab	Etiquetas MSS/ MMRp

Showing 231 to 240 of 299 entries